Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001383885 | SCV001583204 | pathogenic | not provided | 2023-11-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.His3287Profs*54) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 28041643). ClinVar contains an entry for this variant (Variation ID: 438035). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002496963 | SCV002810918 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2022-02-04 | criteria provided, single submitter | clinical testing | |
SN ONGC Dept of Genetics and Molecular biology Vision Research Foundation | RCV000504990 | SCV003927119 | pathogenic | Usher syndrome | 2022-12-31 | criteria provided, single submitter | research | |
Neuberg Centre For Genomic Medicine, |
RCV001829439 | SCV004100575 | pathogenic | Usher syndrome type 2A | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV003449430 | SCV004182641 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001829439 | SCV004182643 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003449430 | SCV004206450 | pathogenic | Retinitis pigmentosa 39 | 2024-02-29 | criteria provided, single submitter | clinical testing | |
NIHR Bioresource Rare Diseases, |
RCV000504834 | SCV000598844 | uncertain significance | Retinitis pigmentosa | 2015-01-01 | no assertion criteria provided | research | |
NIHR Bioresource Rare Diseases, |
RCV000504990 | SCV000598845 | uncertain significance | Usher syndrome | 2015-01-01 | no assertion criteria provided | research | |
Natera, |
RCV001829439 | SCV002088381 | pathogenic | Usher syndrome type 2A | 2021-04-15 | no assertion criteria provided | clinical testing |